CCX-354-C

CCX-354-C · Amgen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CCX-354-C, covering 2025-03-06 to 2025-03-06. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Safety and Efficacy of CCX 354-C in Subjects With Rheumatoid Arthritis [Phase 1, Phase 2]